{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:43:58Z","timestamp":1784389438060,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10620-025-09399-9","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T04:37:13Z","timestamp":1758170233000},"page":"524-533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reassessing Vonoprazan for Endoscopy-Negative Reflux Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"71","author":[{"given":"Minahil","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ahsan","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humza","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufyan","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Shahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arfa Ahmed","family":"Assad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeem","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassam","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"9399_CR1","doi-asserted-by":"crossref","unstructured":"Boulton KHA, Dettmar PW. A narrative review of the prevalence of gastroesophageal reflux disease (GERD). Vol. 5, Annals of Esophagus. 2022.","DOI":"10.21037\/aoe-20-80"},{"key":"9399_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5056\/jnm.2010.16.1.8","volume":"16","author":"T Hershcovici","year":"2010","unstructured":"Hershcovici T, Fass R. Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil. 2010;16:8.","journal-title":"J Neurogastroenterol Motil."},{"key":"9399_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11894-008-0044-5","volume":"10","author":"JD Long","year":"2008","unstructured":"Long JD, Orlando RC. Nonerosive reflux disease: A pathophysiologic perspective. Current Gastroenterology Reports. 2008;10:200\u2013207.","journal-title":"Current Gastroenterology Reports."},{"key":"9399_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/01.mcg.0000225631.07039.6d","volume":"41","author":"R Fass","year":"2007","unstructured":"Fass R. Erosive esophagitis and nonerosive reflux disease (NERD): Comparison of epidemiologic, physiologic, and therapeutic characteristics. Journal of Clinical Gastroenterology. 2007;41:131\u2013137.","journal-title":"Journal of Clinical Gastroenterology."},{"key":"9399_CR5","first-page":"733","volume":"20","author":"CJ Ketchem","year":"2024","unstructured":"Ketchem CJ, Lynch KL. Potassium-Competitive Acid Blockers and Proton Pump Inhibitors: The Dynamic Duo of Acid Blockers. Gastroenterology & Hepatology. 2024;20:733.","journal-title":"Gastroenterology & Hepatology."},{"key":"9399_CR6","doi-asserted-by":"publisher","first-page":"653989","DOI":"10.1155\/2013\/653989","volume":"2013","author":"CL Chen","year":"2013","unstructured":"Chen CL, Hsu PI. Current advances in the diagnosis and treatment of nonerosive reflux disease. Gastroenterology Research and Practice. 2013;2013:653989.","journal-title":"Gastroenterology Research and Practice."},{"key":"9399_CR7","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1053\/j.gastro.2024.06.038","volume":"167","author":"A Patel","year":"2024","unstructured":"Patel A, Laine L, Moayyedi P, Wu J. AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers into Clinical Practice: Expert Review. Gastroenterology 2024;167:1228\u20131238.","journal-title":"Gastroenterology"},{"key":"9399_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/263451612513258.","author":"S Spechler","year":"2025","unstructured":"Spechler S, Kolb JM, Dunbargave K et al. American Foregut Society White Paper Report on the Use of Potassium-Competitive Acid Blockers in the Treatment of Gastroesophageal Reflux Disease. Foregut. 2025. https:\/\/doi.org\/10.1177\/263451612513258.","journal-title":"Foregut"},{"key":"9399_CR9","volume-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews, vol372. The BMJ: BMJ Publishing Group; 2021."},{"key":"9399_CR10","unstructured":"Front Matter. In: Cochrane Handbook for Systematic Reviews of Interventions. Wiley; 2019."},{"key":"9399_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/jrsm.1316.","volume":"10","author":"D Langan","year":"2019","unstructured":"Langan D, Higgins JPT, Jackson D et al. A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses. Res Synth Methods. 2019;10:83\u201398. https:\/\/doi.org\/10.1002\/jrsm.1316.","journal-title":"Res Synth Methods."},{"key":"9399_CR12","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses Testing for heterogeneity."},{"key":"9399_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.curtheres.2016.12.001","volume":"81\u201382","author":"Y Kinoshita","year":"2016","unstructured":"Kinoshita Y, Sakurai Y, Shiino M et al. Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study. Curr Ther Res Clin Exp. 2016;81\u201382:1\u20137.","journal-title":"Curr Ther Res Clin Exp."},{"key":"9399_CR14","doi-asserted-by":"publisher","first-page":"e00101","DOI":"10.14309\/ctg.0000000000000101","volume":"10","author":"Y Kinoshita","year":"2019","unstructured":"Kinoshita Y, Sakurai Y, Takabayashi N et al. Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study. Clin Transl Gastroenterol. 2019;10:e00101.","journal-title":"Clin Transl Gastroenterol."},{"key":"9399_CR15","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.cgh.2024.05.004","volume":"22","author":"L Laine","year":"2024","unstructured":"Laine L, Spechler S, Yadlapati R et al. Vonoprazan is Efficacious for Treatment of Heartburn in Non-erosive Reflux Disease: A Randomized Trial. Clinical Gastroenterology and Hepatology. 2024;22:2211\u20132220.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"9399_CR16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/apt.17728","volume":"58","author":"R Fass","year":"2023","unstructured":"Fass R, Vaezi M, Sharma P et al. Randomised clinical trial: Efficacy and safety of on-demand vonoprazan versus placebo for non-erosive reflux disease. Aliment Pharmacol Ther. 2023;58:1016\u20131027.","journal-title":"Aliment Pharmacol Ther."},{"key":"9399_CR17","doi-asserted-by":"publisher","first-page":"4785077","DOI":"10.1155\/2022\/4785077","volume":"2022","author":"C Xu","year":"2022","unstructured":"Xu C, Niu X. Progress on the Mechanism of Visceral Hypersensitivity in Nonerosive Reflux Disease. Gastroenterology Research and Practice. 2022;2022:4785077.","journal-title":"Gastroenterology Research and Practice."},{"key":"9399_CR18","unstructured":"Fass R, Dickman R. Nonerosive reflux disease. GI Motility online [Internet]. 2006 May 16; Available from: nature.com\/gimo\/contents\/pt1\/full\/gimo42.html"},{"key":"9399_CR19","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.cgh.2020.03.057","volume":"19","author":"D Patel","year":"2021","unstructured":"Patel D, Fass R, Vaezi M. Untangling Nonerosive Reflux Disease from Functional Heartburn. Clinical Gastroenterology and Hepatology. 2021;19:1314\u20131326.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"9399_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","volume":"117","author":"PO Katz","year":"2022","unstructured":"Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology. 2022;117:27\u201356.","journal-title":"American Journal of Gastroenterology."},{"key":"9399_CR21","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/jgh.16486","volume":"39","author":"DM Simadibrata","year":"2024","unstructured":"Simadibrata DM, Lesmana E, Fass R. Vonoprazan is superior to lansoprazole for healing of severe but not mild erosive esophagitis: A systematic review with meta-analysis of randomized controlled trials. Journal of Gastroenterology and Hepatology (Australia). 2024;39:988\u2013999.","journal-title":"Journal of Gastroenterology and Hepatology (Australia)."},{"key":"9399_CR22","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/jgh.16475","volume":"39","author":"DM Simadibrata","year":"2024","unstructured":"Simadibrata DM, Lesmana E, Fass R. A systematic review and meta-analysis of the efficacy of vonoprazan for proton pump inhibitor-resistant gastroesophageal reflux disease. Journal of Gastroenterology and Hepatology (Australia). 2024;39:796\u2013805.","journal-title":"Journal of Gastroenterology and Hepatology (Australia)."},{"key":"9399_CR23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S1542-3565(04)00288-5","volume":"2","author":"BB Dean","year":"2004","unstructured":"Dean BB, Gano AD, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clinical Gastroenterology and Hepatology. 2004;2:656\u2013664.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"9399_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1365-2982.2012.01977.x","volume":"24","author":"C Scarpignato","year":"2012","unstructured":"Scarpignato C. Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: The truth in the end! Neurogastroenterology and Motility. 2012;24:697\u2013704.","journal-title":"Neurogastroenterology and Motility."},{"key":"9399_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/gut.2004.043984.","volume":"54","author":"D Sifrim","year":"2005","unstructured":"Sifrim D. Relevance of volume and proximal extent of reflux in gastro-oesophageal reflux disease. Gut. 2005;54:175\u2013178. https:\/\/doi.org\/10.1136\/gut.2004.043984.","journal-title":"Gut."},{"key":"9399_CR26","doi-asserted-by":"publisher","first-page":"e00488","DOI":"10.14309\/ctg.0000000000000488.","volume":"13","author":"AM Alleleyn","year":"2022","unstructured":"Alleleyn AM, Keszthelyi D, Rinsma NF et al. The Potential Role for Impaired Mucosal Integrity in the Generation of Esophageal Pain Using Capsaicin in Humans: An Explorative Study. Clinical and Translational Gastroenterology. 2022;13:e00488. https:\/\/doi.org\/10.14309\/ctg.0000000000000488.","journal-title":"Clinical and Translational Gastroenterology."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09399-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09399-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09399-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:01:32Z","timestamp":1772092892000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09399-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["9399"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09399-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.G. Adler: Consultant for Boston Scientific. Other authors certify that they have NO affiliations with or involvement in any organization or entity with any financial interest. The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No ethical approval was required for this study design, as all data were obtained from publicly available sources.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}